Pricing And R&D Transparency Proposals Face Pushback At WHA

 
• By Francesca Bruce

A draft resolution on the transparency of medicine prices and R&D costs is being discussed this week by World Health Organization members, but the pharmaceutical industry says some measures will be damaging for medicines access.

Sphere
WHO Member States Are Calling For More Transparency On Pricing And R&D Costs

More from Government Payers

More from Market Access